Intervention Review

Dehydroepiandrosterone for systemic lupus erythematosus

  1. David Crosbie1,*,
  2. Corri Black2,
  3. Linda McIntyre3,
  4. Pamela Royle4,
  5. Sian Thomas3

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 29 JUN 2007

DOI: 10.1002/14651858.CD005114.pub2


How to Cite

Crosbie D, Black C, McIntyre L, Royle P, Thomas S. Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005114. DOI: 10.1002/14651858.CD005114.pub2.

Author Information

  1. 1

    Aberdeen Royal Infirmary, Department of Rheumatology, Aberdeen, UK

  2. 2

    University of Aberdeen, Department of Public Health, Aberdeen, Scotland, UK

  3. 3

    c/o University of Aberdeen, Aberdeen, UK

  4. 4

    University of Aberdeen, School of Medicine, Department of Public Health, Aberdeen, UK

*David Crosbie, Department of Rheumatology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25, UK. David.Crosbie@sgh.scot.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

  1. Current Version

    Dehydroepiandrosterone for systemic lupus erythematosus

    David Crosbie, Corri Black, Linda McIntyre, Pamela Royle and Sian Thomas

    Version of Record online: 17 OCT 2007 | DOI: 10.1002/14651858.CD005114.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Dehydroepiandrosterone for systemic lupus erythematosus

    C Black, D Crosbie, L McIntyre, PL Royle and S Thomas

    Version of Record online: 24 JAN 2005 | DOI: 10.1002/14651858.CD005114